Health Condition 1: K055- Other periodontal diseases Health Condition 2: K054- Periodontosis
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Randomized split mouth clinical trial in 30 patients with Stage II Grade B periodontitis Test sites received SRP plus indigenously prepared atorvastatin gel control sites received SRP alone Clinical parameters PI GI mSBI PPD CAL assessed at baseline and 3 months to evaluate adjunctive effectiveness
Exclusion criteria
Exclusion criteria: Patients with systemic disease Patients on systemic atorvastatin or other statin therapy Pregnant or lactating females Tobacco users in any form Patients with poor oral hygiene or non compliant behavior Patients who have undergone periodontal treatment in the last 6 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in plaque index gingival index clinical attachment lossTimepoint: Baseline and 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Assessment of adverse effects and patient compliance during treatment periodTimepoint: Change in PI GI mSBI PPD CAL | — |
Countries
India
Contacts
Pravara institute of medical sciences